China Universal Asset Management Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
DC
BHIA
China Universal Asset Management Company's VRTX Position: Q2 2026 in Review
China Universal Asset Management Company increased its Vertex Pharmaceuticals (VRTX) stake by 9.9% in Q2 2026, buying an estimated $1.93M and bringing the position to 48,265 shares worth $24M. The position accounts for 1.43% of the portfolio, ranked #16.
China Universal Asset Management Company first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. 578 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- China Universal Asset Management Company held 48,265 shares of Vertex Pharmaceuticals worth $24M as of Q2 2026.
- China Universal Asset Management Company bought 4,363 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.93M.
- Vertex Pharmaceuticals made up 1.43% of China Universal Asset Management Company's portfolio in Q2 2026, its #16 holding.
- China Universal Asset Management Company first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- 578 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.